Literature DB >> 31663976

Clinicians' Use of Intravaginal Boric Acid Maintenance Therapy for Recurrent Vulvovaginal Candidiasis and Bacterial Vaginosis.

Anna Powell1, Khalil G Ghanem2, Linda Rogers1, Ashley Zinalabedini1, Rebecca M Brotman3, Jonathan Zenilman2, Susan Tuddenham2.   

Abstract

A retrospective chart review characterized clinicians' use of maintenance intravaginal boric acid for women with recurrent vulvovaginal candidiasis or bacterial vaginosis. Average length of use was 13 months with high patient satisfaction and few adverse events. Prospective studies are needed to evaluate the efficacy of maintenance boric acid for these conditions.

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31663976      PMCID： PMC6878170          DOI： 10.1097/OLQ.0000000000001063

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN： 0148-5717            Impact factor:   2.830


  16 in total

1.  Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.

Authors:  Kimberly A Workowski
Journal:  Clin Infect Dis       Date:  2015-12-15       Impact factor: 9.079

2.  Chronic suppurative otitis media due to nontuberculous mycobacteria: A case of successful treatment with topical boric acid.

Authors:  Marie-Astrid Lefebvre; Caroline Quach; Sam J Daniel
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2015-05-08       Impact factor: 1.675

3.  Efficacy of maintenance therapy with topical boric acid in comparison with oral itraconazole in the treatment of recurrent vulvovaginal candidiasis.

Authors:  S Guaschino; F De Seta; A Sartore; G Ricci; D De Santo; M Piccoli; S Alberico
Journal:  Am J Obstet Gynecol       Date:  2001-03       Impact factor: 8.661

Review 4.  Boric acid for recurrent vulvovaginal candidiasis: the clinical evidence.

Authors:  Christos Iavazzo; Ioannis D Gkegkes; Ioanna M Zarkada; Matthew E Falagas
Journal:  J Womens Health (Larchmt)       Date:  2011-07-20       Impact factor: 2.681

Review 5.  Current Treatment of Bacterial Vaginosis-Limitations and Need for Innovation.

Authors:  Catriona S Bradshaw; Jack D Sobel
Journal:  J Infect Dis       Date:  2016-08-15       Impact factor: 5.226

6.  Boric acid addition to suppressive antimicrobial therapy for recurrent bacterial vaginosis.

Authors:  Orna Reichman; Robert Akins; Jack D Sobel
Journal:  Sex Transm Dis       Date:  2009-11       Impact factor: 2.830

Review 7.  Molecular Diagnosis of Bacterial Vaginosis: an Update.

Authors:  Jenell S Coleman; Charlotte A Gaydos
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 5.948

8.  Vaginitis due to Saccharomyces cerevisiae: epidemiology, clinical aspects, and therapy.

Authors:  J D Sobel; J Vazquez; M Lynch; C Meriwether; M J Zervos
Journal:  Clin Infect Dis       Date:  1993-01       Impact factor: 9.079

9.  Safety and Efficacy of a Novel Vaginal Anti-infective, TOL-463, in the Treatment of Bacterial Vaginosis and Vulvovaginal Candidiasis: A Randomized, Single-blind, Phase 2, Controlled Trial.

Authors:  Jeanne M Marrazzo; Julia C Dombrowski; Michael R Wierzbicki; Charlotte Perlowski; Angela Pontius; Dwyn Dithmer; Jane Schwebke
Journal:  Clin Infect Dis       Date:  2019-02-15       Impact factor: 9.079

Review 10.  Current treatment options for vulvovaginal candidiasis caused by azole-resistant Candida species.

Authors:  J D Sobel; R Sobel
Journal:  Expert Opin Pharmacother       Date:  2018-06-22       Impact factor: 3.889
View more
  4 in total

1.  Antifungal activity of boric acid, triclosan and zinc oxide against different clinically relevant Candida species.

Authors:  Marly Alejandra Gavilanes-Martínez; Alejandra Coral-Garzón; Diego H Cáceres; Ana María García
Journal:  Mycoses       Date:  2021-06-05       Impact factor: 4.931

2.  A Cationic Amphipathic Tilapia Piscidin 4 Peptide-Based Antimicrobial Formulation Promotes Eradication of Bacterial Vaginosis-Associated Bacterial Biofilms.

Authors:  Wen-Chun Lin; Yun-Ru Chen; Chi-Mu Chuang; Jyh-Yih Chen
Journal:  Front Microbiol       Date:  2022-03-23       Impact factor: 6.064

3.  Comparative Fungicidal Activities of N-Chlorotaurine and Conventional Antiseptics against Candida spp. Isolated from Vulvovaginal Candidiasis.

Authors:  Mayram Hacioglu; Ozlem Oyardi; Fatima Nur Yilmaz; Markus Nagl
Journal:  J Fungi (Basel)       Date:  2022-06-28

4.  Effects of Boric Acid Gel on Vaginal Candida albicans Infections and the Local Immune System in Mice.

Authors:  Xiaoyu Guo; Tingting Jing; Xiaojing Li; Zhao Liu; Yongxue Chen; Yiquan Li; Yanyan Xu; Hongqi Gao
Journal:  Front Immunol       Date:  2022-07-25       Impact factor: 8.786
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.